- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westbrook Today
By the People, for the People
Quantum Capital Reduces Stake in IDEXX Laboratories
Hedge fund cuts position in veterinary diagnostics company by 25.5%
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
Quantum Capital Management LLC NJ, a New Jersey-based investment firm, reduced its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 25.5% in the third quarter. The firm now owns 77,825 shares of the company's stock, valued at $49.72 million, making it IDEXX's 8th largest institutional investor.
Why it matters
IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. The company's stock has been a strong performer, but this reduction in ownership by a major investor could signal potential concerns about the company's future growth prospects.
The details
According to a filing with the Securities and Exchange Commission, Quantum Capital Management sold 26,602 shares of IDEXX Laboratories during the third quarter, reducing its total position to 77,825 shares. The firm cited unspecified reasons for the reduction in its IDEXX holdings, which previously accounted for approximately 5.5% of its overall portfolio.
- Quantum Capital Management reduced its IDEXX Laboratories position in the third quarter of 2026.
The players
Quantum Capital Management LLC NJ
A New Jersey-based investment management firm that reduced its stake in IDEXX Laboratories by 25.5% in the third quarter of 2026.
IDEXX Laboratories, Inc.
An American company that develops, manufactures, and provides diagnostic products and services primarily for the animal health, water testing, and food safety markets.
The takeaway
This reduction in ownership by a major institutional investor could signal potential concerns about IDEXX Laboratories' future growth prospects, even as the company remains a leader in the veterinary diagnostics market. Investors will be closely watching the company's performance and any further changes in institutional ownership.
